Publicly Traded Biotech Firm 180 Life Sciences Plans Ethereum Treasury With Yield Generation Ambitions

Key Points

1. 180 Life Sciences has rebranded as ETHZilla and announced a $425 million PIPE offering priced at $2.65 per share, backed by over 60 institutional and crypto-native investors.

2. ETHZilla plans to generate 3-10% annual yield through innovative on-chain strategies, aiming to outperform traditional ETH staking returns.

3. The company's strategy involves reinvesting yield-generated cash flows to acquire more Ethereum, positioning itself as a dominant player in the Ethereum treasury sector.

4. ETHZilla's stock (ATNF) saw a 10% increase following the announcement, reflecting market confidence in its new strategy.

5. The company combines institutional capital with expert yield generation, leveraging Ethereum's financial ecosystem to enhance shareholder value.